Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhixue Zhitong Jiaonang is a traditional Chinese medicine (TCM) capsule developed and manufactured by Chengdu Jiuzhitang Jinding Pharmaceutical, a subsidiary of Jiuzhitang. It is primarily indicated for the treatment of various types of bleeding and associated pain, including traumatic injuries, surgical hemorrhage, and internal bleeding such as gastrointestinal or uterine hemorrhage. The formulation is based on TCM principles of cooling the blood to stop bleeding and resolving blood stasis to alleviate pain. Key herbal components typically include *Panax notoginseng* (Sanqi), *Pollen Typhae* (Puhuang), and *Dalbergia odorifera* (Jiangxiang), which work synergistically to promote hemostasis and provide analgesic effects. The product is approved for marketing in China and is recognized as a National Chinese Medicine Protection Variety.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zhixue zhitong jiaonang.